Fertility Ovulation Devices Market By Product Type (Ovulation Prediction Kits; Fertility Monitors [Urine-based Monitors; Saliva-based Monitors; Wearable Fertility Trackers]; Basal Body Temperature [BBT] Devices; Smart Fertility Apps); By Mode of Purchase (Over-the-Counter [OTC] Devices; Prescription-based Devices); By End-User (Homecare Settings; Hospitals & Clinics; Fertility Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Fertility Ovulation Devices Market Size & Overview

The Fertility Ovulation Devices Market was valued at $790.6 million in 2024 and is projected to reach $1,173.5 million by 2030, growing at a CAGR of 6.8% during the forecast period. The market is experiencing significant growth, driven by increasing awareness about reproductive health, rising infertility rates, and advancements in ovulation tracking technologies.

 

These devices, including ovulation predictor kits, fertility monitors, basal body temperature (BBT) thermometers, and wearable sensors, help women track their ovulation cycles for family planning and infertility treatment. The market is also witnessing rapid innovation with the integration of AI-driven fertility apps, Bluetooth-enabled fertility monitors, and saliva-based ovulation tests. Additionally, e-commerce platforms and telemedicine consultations are enhancing accessibility, allowing consumers to purchase fertility tracking devices conveniently. While North America holds the largest market share, driven by advanced healthcare infrastructure and strong consumer awareness, the APAC region is expected to witness the highest growth due to rising infertility cases, increased disposable income & growing adoption of digital health solutions.

 

Fertility Ovulation Devices Market Dynamics:

Market Drivers:

Rising Prevalence of Infertility & Delayed Pregnancies

Infertility rates are on the rise globally due to factors such as lifestyle changes, stress, obesity, and hormonal disorders like PCOS (Polycystic Ovary Syndrome). There used to be a worldwide average of 5 children per woman in 1950, but in 2020, that average has fallen to 2 children according to the UN. Around 17.5% of the adult population roughly 1 in 6 worldwide experience infertility, showing the urgent need to increase access to affordable, high-quality fertility care for those in need. According to the WHO, nearly 48 million couples & 186 million individuals worldwide experience infertility. Additionally, more women are opting for late pregnancies due to career priorities, leading to a higher demand for ovulation tracking and fertility monitoring devices. As a result, fertility awareness methods (FAMs) and digital ovulation tracking solutions are gaining popularity.

Growing Adoption of At-Home Fertility Monitoring Solutions

With the increasing focus on personalized & accessible healthcare, there is a growing demand for at-home fertility tracking kits & digital applications. The rise of smartphone-based ovulation apps & wearable fertility monitors has made fertility tracking easier & more convenient.  The Flo Period & Ovulation Tracker App has over 300 Mn users worldwide, while digital ovulation tracking devices like Ava Bracelet & Ovusense provide real-time fertility insights, further driving market growth.

 

Market Opportunities:

Technological Advancements in Ovulation & Fertility Tracking Devices

The integration of AI, machine learning, and biosensor technology is creating new growth opportunities in the fertility & ovulation devices market. Smart fertility devices with continuous temperature monitoring, hormonal analysis, and predictive analytics are gaining traction. The Mira Fertility Tracker uses AI-driven hormone analysis to provide personalized fertility insights, enhancing accuracy compared to traditional methods. These innovations offer a significant opportunity for companies developing non-invasive, real-time fertility monitoring solutions.

Expanding Market in Emerging Economies

Countries in Asia-Pacific, Latin America & the Middle East are witnessing a rising demand for fertility solutions due to increasing awareness, improving healthcare infrastructure & growing medical tourism. In India alone, the fertility industry is expected to grow at a CAGR of over 15%, fueled by rising infertility rates and the availability of affordable fertility treatments. Government initiatives promoting women’s reproductive health awareness & fertility wellness programs in countries like China & Brazil further present lucrative growth opportunities for market players.

 

Market Restraints:

High Cost of Advanced Fertility Monitoring Devices

Despite the increasing adoption of fertility tracking solutions, cost remains a significant barrier, particularly in middle & low income countries. Advanced ovulation tracking devices like Ovusense & Ava Fertility Tracker can cost between $200 - $400 per device, making them inaccessible to a large segment of the population. Moreover, insurance coverage for fertility tracking & treatment is limited, further restricting market penetration, especially in developing regions.

Limited Accuracy & Reliability of Certain Ovulation Tracking Methods

While technological advancements have improved fertility tracking, traditional ovulation prediction methods such as basal body temperature (BBT) monitoring & urine-based ovulation tests still face accuracy challenges due to external factors like stress, illness, and lifestyle variations. Studies have shown that BBT tracking alone has an accuracy of around 70-80%, which may lead to missed ovulation windows or incorrect predictions. This limitation discourages some consumers from relying on fertility tracking devices, impacting market growth.

 

Fertility Ovulation Devices Market Segmentation: A Comprehensive Overview

By Product Type

• Ovulation Prediction Kits

• Fertility Monitors

  • Urine-based Monitors

  • Saliva-based Monitors

  • Wearable Fertility Trackers

• Basal Body Temperature (BBT) Devices

• Smart Fertility Apps

 

By Mode of Purchase

• Over-the-Counter (OTC) Devices

• Prescription-based Devices

 

By End-User

• Homecare Settings

• Hospitals & Clinics

• Fertility Centers

 

By Region

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East & Africa

 

Fertility Ovulation Devices Market Segment Analysis: Growth Trends Across Categories

By Product Type:

Leading Segment: Ovulation Prediction Kits

Ovulation prediction kits hold the largest market share in the fertility ovulation devices market. These kits are widely used by individuals & couples to predict ovulation, which helps improve the chances of conception. The high demand for ovulation prediction kits is driven by their accessibility, simplicity & cost-effectiveness. They are particularly popular among women trying to conceive without seeking medical intervention. The growing awareness about fertility issues, as well as increasing use in family planning, contributes to the market dominance of this segment. Ovulation prediction kits account for approximately 35-40% of the overall market share.

Fastest-Growing Segment: Smart Fertility Apps

Smart fertility apps are the fastest-growing segment in the fertility ovulation devices market, with a compound annual growth rate (CAGR) of around 17-20% from 2024 to 2030. The rapid growth is propelled by the increasing adoption of smartphones & the growing preference for non-invasive and personalized fertility tracking. These apps allow users to track ovulation, menstrual cycles & other fertility-related metrics. As people look for more convenient, cost-effective & technology-driven solutions, the demand for smart fertility apps is expected to rise significantly in the coming years.

 

By Mode of Purchase:

Leading Segment: Over-the-Counter (OTC) Devices

Over-the-counter devices represent the largest share in the fertility ovulation devices market. These devices are readily available in pharmacies, supermarkets & online stores, making them highly accessible for consumers. OTC devices, such as ovulation prediction kits & basal body temperature devices, are favored for their ease of use & lower cost. The convenience of direct consumer access is a major driver of growth in this segment, with OTC devices accounting for approximately 60-65% of the total market share.

Fastest-Growing Segment: Prescription-based Devices

Prescription-based fertility ovulation devices are the fastest-growing segment, with a projected CAGR of around 12-15%. This growth is attributed to increasing awareness & the rise in assisted reproductive technologies (ART). Prescription devices, which include more advanced & medically accurate options, are becoming more sought after for clinical and fertility treatments, such as IVF & hormone therapies.

 

By End-User:

Leading Segment: Homecare Settings

Homecare settings lead the fertility ovulation devices market due to the growing trend of self-monitoring and home-based fertility solutions. Women increasingly prefer using ovulation prediction kits, fertility monitors, and basal body temperature devices at home to track their fertility cycles. The convenience, privacy & affordability offered by homecare settings are key factors in this segment's dominance. This segment holds a share of around 50-55% of the overall market.

Fastest-Growing Segment: Fertility Centers

Fertility centers are the fastest-growing end-user segment for fertility ovulation devices, expanding at a CAGR of approximately 10-12%. As assisted reproductive technologies & fertility treatments gain popularity, fertility centers are increasingly adopting advanced devices, such as wearable fertility trackers & prescription-based monitors, for better treatment outcomes. The growth is driven by a higher volume of patients seeking professional fertility care, coupled with technological advancements.

 

By Region:

Leading Region: North America

North America holds the largest market share for fertility ovulation devices, driven by high awareness levels, increasing infertility rates & a strong demand for family planning and reproductive health products. The United States accounts for the largest portion of this market, thanks to the widespread availability of fertility ovulation devices in retail and online platforms. North America is expected to maintain a market share of around 40-45% over the forecast period.

Fastest-Growing Region: Asia-Pacific

The APAC region is the fastest-growing market for fertility ovulation devices, projected to grow at a CAGR of 14-16%. This growth is attributed to the rising awareness of fertility issues, increasing disposable incomes, and the growing demand for fertility products in countries such as China, India, and Japan. The APAC region's rapidly expanding healthcare infrastructure and increased focus on reproductive health are significant contributors to the rising demand for fertility ovulation devices in the region.

 

Fertility Ovulation Devices Market Report Coverage

Report Attribute	Details
Forecast Period	2024 – 2032
Market Size Value in 2024	USD 790.6 Million
Revenue Forecast in 2030	USD 1,173.5 Million
Overall Growth Rate	CAGR of 6.8% (2024 – 2030)
Base Year for Estimation	2024
Historical Data	2017 – 2021
Unit	USD Million, CAGR (2024 – 2030)
Segmentation	By Product Type, By Mode of Purchase, By End-User, By Geography
By Product Type	Ovulation Prediction Kits; Fertility Monitors (Urine-based Monitors; Saliva-based Monitors; Wearable Fertility Trackers); Basal Body Temperature (BBT) Devices; Smart Fertility Apps
By Mode of Purchase	Over-the-Counter (OTC) Devices; Prescription-based Devices
By End-User	Homecare Settings; Hospitals & Clinics; Fertility Centers
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	US, Canada, Germany, China, India, etc.
Market Drivers	Rising infertility rates, increasing awareness about fertility monitoring, advancements in wearable health technology
Pricing and Purchase Options	Customized options available

 

Key Players in the Fertility Ovulation Devices Market

• Clearblue (SPD Swiss Precision Diagnostics GmbH)

• Ava Science Inc.

• OvuSense (ViO HealthTech Ltd.)

• Tempdrop

• Mira Fertility

• Everlywell

• Premom (Easy@Home Healthcare Corporation)

• Modern Fertility (acquired by Ro Health)

• iProven

• Kindara (Good Start Genetics Inc.)

 

Recent Developments

• In December 2024, Clearblue introduced the Advanced Digital Ovulation Test, designed to identify typically four or more fertile days per cycle. This test tracks two key fertility hormones: estrogen & luteinizing hormone (LH) to provide users with a broader fertility window, enhancing the chances of conception. The digital interface offers clear results, making it user-friendly for individuals seeking to monitor their fertility. 

• In early 2025, Mira Fertility launched the Mira Fertility Max Starter Kit, a high-tech device capable of predicting and confirming ovulation in 20 minutes or less. Users collect a urine sample, dip a provided test wand, and insert it into the digital monitor. The monitor then delivers detailed reports via an app, charting estrogen, LH, and progesterone levels to assess fertility status accurately.

 

Future Outlook

The future outlook for the fertility and ovulation devices market is highly promising, driven by increasing infertility rates, growing awareness of reproductive health & advancements in digital health technologies. The demand for non-invasive, AI-powered fertility tracking solutions is expected to surge as consumers seek more personalized & data-driven insights into their menstrual & ovulation cycles. The integration of wearable devices, smartphone-based ovulation detectors & AI-driven hormonal tracking is set to revolutionize the market, offering real-time, highly accurate fertility predictions. Additionally, the rise of telehealth & home-based fertility monitoring is making fertility tracking more accessible, particularly in emerging economies where traditional fertility treatments can be expensive or inaccessible. However, high costs of advanced ovulation devices & concerns over accuracy in traditional tracking methods may pose challenges to widespread adoption. Despite these barriers, continued investments in digital health, biosensor technology & hormonal analytics are expected to drive innovation and expand market penetration, positioning fertility and ovulation devices as essential tools for reproductive health management in the coming years.